학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 6건 | 목록
1~20
Academic Journal
Liaki V; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Barrambana S; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Kostopoulou M; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Lechuga CG; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Zamorano-Dominguez E; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid 28029, Spain.; Acosta D; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Morales-Cacho L; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Álvarez R; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Sun P; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Rosas-Perez B; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Barrero R; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Jiménez-Parrado S; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; López-García A; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; San Roman M; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; López-Gil JC; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Drosten M; Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid 28029, Spain.; Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas-Universidad de Salamanca (CSIC-USAL), Salamanca 37007, Spain.; Sainz B Jr; Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid 28029, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Instituto de Investigaciones Biomédicas Sols-Morreale Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid 28029, Spain.; Biomarkers and Personalized Approach to Cancer Group, Area 3 Cáncer, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid 28049, Spain.; Musteanu M; Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid 28029, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Universidad Complutense, Madrid 28040, Spain.; Cancer and Obesity Group, Instituto de Investigación Sanitaria Hospital Clínico San Carlos, Madrid 28040, Spain.; Caleiras E; Histopathology Unit, Biotechnology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Dusetti N; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes; Parc Scientifique et Technologique de Luminy, Marseille 13288, France.; Poli V; Molecular Biotechnology Center and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin 101214, Italy.; Sánchez-Bueno F; Department of Surgery, Hospital Clinico Universitario Virgen de la Arrixaca and Instituto Murciano de Investigación Biomédica, Murcia 30120, Spain.; Guerra C; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid 28029, Spain.; Barbacid M; Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid 28029, Spain.
Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Academic Journal
Zamorano-Dominguez E; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid 28029, Spain.; Morales-Cacho L; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Barrero R; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Jiménez-Parrado S; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Dhawahir A; Global Pharma Strategy, F. Hoffmann-La Roche Ltd, Basil 4070, Switzerland.; Hernández-Porras I; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Simón-Carrasco L; Molecular Oncology and Targeted Therapies Group, Centro Andaluz de Biología Molecular y Medicina Regenerativa, Consejo Superior de Investigaciones Científicas-Universidad de Sevilla-Universidad Pablo de Olavide, Seville 41092, Spain.; Barrambana S; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Sun P; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Galván-Del-Rey A; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Rosas-Perez B; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Liaki V; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Drosten M; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid 28029, Spain.; RAS Signalling and Lung Cancer Group, Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas-Universidad de Salamanca, Salamanca 37007, Spain.; Musteanu M; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid 28029, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Universidad Complutense de Madrid, Madrid 28040, Spain.; Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid 28040, Spain.; Virga F; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Inmunobiology Unit, Centro Nacional de Investigaciones Cardiovasculares, Madrid 28029, Spain.; Santos E; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid 28029, Spain.; RAS Signalling and Lung Cancer Group, Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas-Universidad de Salamanca, Salamanca 37007, Spain.; Mulero F; Molecular Imaging Unit, Biotechnology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Caleiras E; Histopathology Unit, Biotechnology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Guerra C; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid 28029, Spain.; Barbacid M; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid 28029, Spain.
Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Academic Journal
Salmón M; Experimental Oncology Group, Molecular Oncology Program.; Álvarez-Díaz R; Experimental Oncology Group, Molecular Oncology Program.; Fustero-Torre C; Bioinformatics Unit.; Brehey O; Experimental Oncology Group, Molecular Oncology Program.; Lechuga CG; Experimental Oncology Group, Molecular Oncology Program.; Sanclemente M; Experimental Oncology Group, Molecular Oncology Program.; Fernández-García F; Experimental Oncology Group, Molecular Oncology Program.; López-García A; Experimental Oncology Group, Molecular Oncology Program.; Martín-Guijarro MC; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program.; Rodríguez-Perales S; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program.; Bousquet-Mur E; Experimental Oncology Group, Molecular Oncology Program.; Morales-Cacho L; Experimental Oncology Group, Molecular Oncology Program.; Mulero F; Molecular Imaging Unit.; Al-Shahrour F; Bioinformatics Unit.; Martínez L; Flow Cytometry Unit.; Domínguez O; Genomics Unit.; Caleiras E; Histopathology Unit, and.; Ortega S; Mouse Genome Editing Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Guerra C; Experimental Oncology Group, Molecular Oncology Program.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Musteanu M; Experimental Oncology Group, Molecular Oncology Program.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University, Madrid, Spain.; Drosten M; Experimental Oncology Group, Molecular Oncology Program.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas-Universidad de Salamanca (CSIC-USAL), Salamanca, Spain.; Barbacid M; Experimental Oncology Group, Molecular Oncology Program.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Academic Journal
Blasco MT; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.; Navas C; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.; Martín-Serrano G; Bioinformatics Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Graña-Castro O; Bioinformatics Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Lechuga CG; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.; Martín-Díaz L; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Djurec M; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Li J; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.; Morales-Cacho L; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.; Esteban-Burgos L; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.; Perales-Patón J; Bioinformatics Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Bousquet-Mur E; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Castellano E; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Jacob HKC; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Cabras L; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Musteanu M; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.; Drosten M; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.; Ortega S; Transgenic Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Mulero F; Molecular Imaging Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Sainz B Jr; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain; Department of Biochemistry, School of Medicine, Autonomous University of Madrid, 28018 Madrid, Spain.; Dusetti N; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm U1068, CNRS UMR 7258, Aix-Marseille Université et Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, 163, Avenue de Luminy, 13288 Marseille, France.; Iovanna J; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm U1068, CNRS UMR 7258, Aix-Marseille Université et Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, 163, Avenue de Luminy, 13288 Marseille, France.; Sánchez-Bueno F; Department of Surgery, Clinical University Hospital 'Virgen Arrixaca' - Murcian Institute of Biomedical Investigation (IMIB), 30120 Murcia, Spain.; Hidalgo M; Rosenberg Clinical Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Khiabanian H; Department of Systems Biology, Columbia University Medical Center, New York, NY 10032, USA.; Rabadán R; Department of Systems Biology, Columbia University Medical Center, New York, NY 10032, USA.; Al-Shahrour F; Bioinformatics Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.; Guerra C; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain. Electronic address: mcguerra@cnio.es.; Barbacid M; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain. Electronic address: mbarbacid@cnio.es.
Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Academic Journal
Ayllón V; Gene Regulation, Stem Cells and Development Group, Department of Genomic Oncology, GENYO-Centre for Genomics and Oncological Research-Pfizer/University of Granada/Junta de Andalucía, PTS Granada, 18016 Granada, Spain. Electronic address: veronica.ayllon@genyo.es.; Vogel-González M; Gene Regulation, Stem Cells and Development Group, Department of Genomic Oncology, GENYO-Centre for Genomics and Oncological Research-Pfizer/University of Granada/Junta de Andalucía, PTS Granada, 18016 Granada, Spain.; González-Pozas F; Gene Regulation, Stem Cells and Development Group, Department of Genomic Oncology, GENYO-Centre for Genomics and Oncological Research-Pfizer/University of Granada/Junta de Andalucía, PTS Granada, 18016 Granada, Spain.; Domingo-Reinés J; Gene Regulation, Stem Cells and Development Group, Department of Genomic Oncology, GENYO-Centre for Genomics and Oncological Research-Pfizer/University of Granada/Junta de Andalucía, PTS Granada, 18016 Granada, Spain.; Montes R; Gene Regulation, Stem Cells and Development Group, Department of Genomic Oncology, GENYO-Centre for Genomics and Oncological Research-Pfizer/University of Granada/Junta de Andalucía, PTS Granada, 18016 Granada, Spain.; Morales-Cacho L; Gene Regulation, Stem Cells and Development Group, Department of Genomic Oncology, GENYO-Centre for Genomics and Oncological Research-Pfizer/University of Granada/Junta de Andalucía, PTS Granada, 18016 Granada, Spain.; Ramos-Mejía V; Gene Regulation, Stem Cells and Development Group, Department of Genomic Oncology, GENYO-Centre for Genomics and Oncological Research-Pfizer/University of Granada/Junta de Andalucía, PTS Granada, 18016 Granada, Spain. Electronic address: veronica.ramos@genyo.es.
Publisher: Elsevier Country of Publication: England NLM ID: 101316957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-7753 (Electronic) Linking ISSN: 18735061 NLM ISO Abbreviation: Stem Cell Res Subsets: MEDLINE
Academic Journal
Domingo-Reines, J.; Gonzalez-Pozas, F.; Morales-Cacho, L.; Vogel-Gonzalez, M.; Rodriguez-Real, G.; Olmedo-Pelayo, J.; Montes, R. M.; Ayllon, V.; Ramos-Mejia, V.
검색 결과 제한하기
제한된 항목
[검색어] Morales-Cacho, L.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어